Constitutive c-Met signaling through a nonautocrine mechanism promotes metastasis in a transgenic transplantation model

Cancer Research

Volumn 62, Issue 10, 2002, Pages 2951-2956

  Yu, Yanlin ^a   Merlino, Glenn ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOCRINE EFFECT; CANCER GROWTH; CELL CYCLE; CELL PROLIFERATION; CELL TRANSPLANTATION; CONTROLLED STUDY; GROWTH STIMULATION; HOMEOSTASIS; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE; TUMOR GROWTH;

ANIMALS; HEPATOCYTE GROWTH FACTOR; LIVER NEOPLASMS, EXPERIMENTAL; LUNG NEOPLASMS; MALE; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICE, NUDE; MICE, TRANSGENIC; NEOPLASM TRANSPLANTATION; PROTO-ONCOGENE PROTEINS C-MET; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 0037093106     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. The hallmarks of cancer
2. Autocrine secretion and malignant transformation of cells
3. Growth factors
4. Hepatocyte growth factor/scatter factor-Met signaling in tumorigenicity and invasion/metastasis
5. Met receptor tyrosine kinase: Enhanced signaling through adapter proteins
6. Structure, tissue-specific expression, and transforming activity of the mouse met protooncogene
7. Scatter factor/hepatocyte growth factor and its receptor the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development
8. The Met proto-oncogene mesenchymal to epithelial cell conversion
9. Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud
10. Scatter factor/hepatocyte growth factor is essential for liver development
11. Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor
12. Hepatocyte growth factor-scatter factor: Mitogen, motogen, and met
13. Domain structure of hepatocyte growth factor/scatter factor (HGF/SF)
14. NK1, a natural splice variant of hepatocyte growth factor/scatter factor, is a partial agonist in vivo
15. Identification of a competitive HGF antagonist encoded by an alternative transcript
16. An alternatively processed mRNA generated from human hepatocyte growth factor gene
17. A functional domain in the heavy chain of scatter factor/hepatocyte growth factor binds the c-Met receptor and induces cell dissociation but not mitogenesis
18. Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-met signalling in human cells concomitant with induction of the urokinase proteolysis network
19. Functional and biophysical characterization of recombinant human hepatocyte growth factor isoforms produced in Escherichia coli
20. Induction of tissue inhibitor of metalloproteinases-3 is a delayed early cellular response to hepatocyte growth factor
21. Differential effects of hepatocyte growth factor isoforms on epithelial and endothelial tubulogenesis
22. Disassociation of met-mediated biological responses in vivo: The natural hepatocyte growth factor/scatter factor splice variant NK2 antagonizes growth but facilitates metastasis
23. Characterization of human transforming genes from chemically transformed, teratocarcinoma, and pancreatic carcinoma cell lines
24. Expression of the c-Met/HGF receptor in human melanocytic neoplasms: Demonstration of the relationship to malignant melanoma tumour progression
25. Regulation of uveal melanoma interconverted phenotype by hepatocyte growth factor/scatter factor (HGF/SF)
26. Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor
27. Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor
28. c-Met autocrine activation induces development of malignant melanoma and acquisition of the metastatic phenotype
29. The coordinated functional expression of epidermal growth factor receptor and c-Met in colorectal carcinoma metastasis
30. The Met/HGF receptor is over-expressed in human osteosarcomas and is activated by either a paracrine or an autocrine circuit
31. Coexpression of hepatocyte growth factor and receptor (Met) in human breast carcinoma
32. Met and hepatocyte growth factor/scatter factor expression in human gliomas
33. Downregulation of E-cadherin and desmoglein I by autocrine hepatocyte growth factor during melanoma development
34. Invasiveness and metastasis of NIH 3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation
35. Autocrine hepatocyte growth factor/scatter factor-Met signaling induces transformation and the invasive/metastatic phenotype in C127 cells
36. The microenvironment of the tumour-host interface
37. Seed and soil revisited: Contribution of the organ microenvironment to cancer metastasis
38. Scatter factor/hepatocyte growth factor as a regulator of skeletal muscle and neural crest development
39. Inhibition of nuclear factor-KB activity is involved in EIA-mediated sensitization of radiation-induced apoptosis
40. Expression of constitutively activated hepatocyte growth factor/scatter factor receptor (c-met) in B16 melanoma cells selected for enhanced liver colonization
41. Landscaping the cancer terrain
42. Tumorigenic conversion of immortal human keratinocytes through stromal cell activation
43. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium
44. Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis
45. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF
46. Scatter factors and invasive growth
47. Serum concentrations of hepatocyte growth factor in breast cancer patients
48. Increase in the circulating level of hepatocyte growth factor in gastric cancer patients
49. Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer
50. Serum hepatocyte growth factor as an index of disease status of patients with colorectal carcinoma
51. Elevation of serum hepatocyte growth factor concentration in patients with gastric cancer is mediated by production from tumor tissue
52. Regulation of scatter factor (hepatocyte growth factor) production by tumor-stroma interaction
53. Primary human fibroblasts induce diverse tumor invasiveness: Involvement of HGF as an important paracrine factor
54. Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: In vitro analysis of tumor-stromal interactions
55. Autocrine and paracrine motility factors and their involvement in invasiveness in a human oral carcinoma cell line
56. Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma
57. Suppression of Ras-mediated tumorigenicity and metastasis through inhibition of the Met receptor tyrosine kinase
58. Overexpression and amplification of the met/HGF receptor gene during the progression of colorectal cancer
59. c-met activation is necessary but not sufficient for liver colonization by B16 murine melanoma cells